BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28024722)

  • 21. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
    Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
    Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
    Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
    Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
    Alabi O; O'Neill JP
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
    Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
    J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
    Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
    Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E1 detection as prognosticator in human papillomavirus-positive head and neck cancers.
    Vivenza D; Lo Nigro C; Denaro N; Fortunato M; Monteverde M; Tonissi F; Lattanzio L; Astesana V; Gloghini A; Volpi CC; Russi E; Merlano MC
    Int J Biol Markers; 2016; 31(2):0. PubMed ID: 27040135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
    Kano M; Kondo S; Wakisaka N; Wakae K; Aga M; Moriyama-Kita M; Ishikawa K; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Kitamura K; Muramatsu M; Yoshizaki T
    Int J Cancer; 2019 Sep; 145(6):1547-1557. PubMed ID: 31228270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case-control study of human papillomavirus and oropharyngeal cancer.
    D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
    N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer.
    Wakisaka N; Yoshida S; Kondo S; Kita M; Endo K; Tsuji A; Murono S; Muramatsu M; Yoshizaki T
    Ann Otol Rhinol Laryngol; 2015 May; 124(5):400-6. PubMed ID: 25423960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population.
    Lucas-Roxburgh R; Benschop J; Lockett B; van den Heever U; Williams R; Howe L
    PLoS One; 2017; 12(10):e0186424. PubMed ID: 29049330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV status and overall survival of patients with oropharyngeal squamous cell carcinoma--a retrospective study of a German head and neck cancer center.
    Tahtali A; Hey C; Geissler C; Filman N; Diensthuber M; Leinung M; Stöver T; Wagenblast J
    Anticancer Res; 2013 Aug; 33(8):3481-5. PubMed ID: 23898123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
    Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
    Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking impact on HPV driven head and neck cancer's oncological outcomes?
    Mirghani H; Leroy C; Chekourry Y; Casiraghi O; Aupérin A; Tao Y; Nguyen F; Caroline E; Breuskin I; Plana AM; Hartl D; Janot F; Temam S; Gorphe P; Blanchard P
    Oral Oncol; 2018 Jul; 82():131-137. PubMed ID: 29909887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
    Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiologic Differences between Human Papillomavirus-Related and Human Papillomavirus-Unrelated Oropharyngeal Carcinoma on Diffusion-Weighted Imaging.
    Chan MW; Higgins K; Enepekides D; Poon I; Symons SP; Moineddin R; Weinreb I; Shearkhani O; Chen A; Beelen J; Chan A; Maralani PJ
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):344-352. PubMed ID: 28245461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.